These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16192609)

  • 41. Recent evidence in the treatment of small hepatocellular carcinoma.
    Kaido T; Uemoto S
    Hepatogastroenterology; 2008; 55(85):1460-2. PubMed ID: 18795712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma.
    Wu XZ; Xie GR; Chen D
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1178-82. PubMed ID: 17559361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Opportunities for targeted therapies in hepatocellular carcinoma.
    Thomas MB; Abbruzzese JL
    J Clin Oncol; 2005 Nov; 23(31):8093-108. PubMed ID: 16258107
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effectiveness of superselective chemoembolization and radiofrequency ablation of hepatocellular carcinoma assessed in 21 explanted livers.
    Lang EK; Brammer M; Charafeddine R; Regenstein F; Haque S; Florman S; Cline K; Slakey D
    J La State Med Soc; 2008; 160(5):258-62. PubMed ID: 19048980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reversing hepatocellular carcinoma progression by using networked biological therapies.
    Epstein RJ; Leung TW
    Clin Cancer Res; 2007 Jan; 13(1):11-7. PubMed ID: 17200333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current approach to down-staging of hepatocellular carcinoma prior to liver transplantation.
    Hanje AJ; Yao FY
    Curr Opin Organ Transplant; 2008 Jun; 13(3):234-40. PubMed ID: 18685309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extending indication: role of living donor liver transplantation for hepatocellular carcinoma.
    Todo S; Furukawa H; Tada M;
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S48-54. PubMed ID: 17969069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Concomitant hepatocellular carcinoma and non-Hodgkin's lymphoma in a patient with nodular regenerative hyperplasia.
    Kataoka TR; Tsukamoto Y; Kanazawa N; Izumi T; Awata N; Nishizawa Y; Ohsawa M; Ishiguro S
    Pathol Int; 2006 May; 56(5):279-82. PubMed ID: 16669877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method--analysis of 2010 Taiwanese patients.
    Chen CH; Hu FC; Huang GT; Lee PH; Tsang YM; Cheng AL; Chen DS; Wang JD; Sheu JC
    Eur J Cancer; 2009 Jun; 45(9):1630-9. PubMed ID: 19157858
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pulmonary embolism: a fatal complication of arterial chemoembolization for advanced hepatocellular carcinoma.
    Czauderna P; Zbrzezniak G; Narozanski W; Sznurkowska K; Skoczylas-Stoba B; Stoba C
    J Pediatr Surg; 2005 Oct; 40(10):1647-50. PubMed ID: 16227000
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emergency transcatheter embolization of ruptured hepatocellular carcinomas with tortuous conventional or aberrant hepatic vascular anatomy, or parasitic supply.
    Lau K; Wong WW; Chan JK; Kan WK; Leung JL; Lee AS; Lee LT; Lee GY
    Australas Radiol; 2007 Apr; 51(2):190-5. PubMed ID: 17419870
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
    Chapman WC; Majella Doyle MB; Stuart JE; Vachharajani N; Crippin JS; Anderson CD; Lowell JA; Shenoy S; Darcy MD; Brown DB
    Ann Surg; 2008 Oct; 248(4):617-25. PubMed ID: 18936575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How can we train doctors to be more humanistic? Case for discussion.
    Brothers PL
    Prog Clin Biol Res; 1980; 38():59-60. PubMed ID: 7384147
    [No Abstract]   [Full Text] [Related]  

  • 54. Diffuse infiltrative hepatocellular carcinomas in a hepatitis B-endemic area: diagnostic and therapeutic impediments.
    Myung SJ; Yoon JH; Kim KM; Gwak GY; Kim YJ; Yu JW; Chung JW; Lee HS
    Hepatogastroenterology; 2006; 53(68):266-70. PubMed ID: 16608037
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter.
    Huang YH; Wu JC; Chen SC; Chen CH; Chiang JH; Huo TI; Lee PC; Chang FY; Lee SD
    Aliment Pharmacol Ther; 2006 Jan; 23(1):129-35. PubMed ID: 16393290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of hepatocellular carcinoma.
    Said A; Wells J
    Minerva Med; 2009 Feb; 100(1):51-68. PubMed ID: 19277004
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hepatocellular carcinoma - diagnosis and treatment].
    Greten TF; Manns MP
    Dtsch Med Wochenschr; 2008 Sep; 133(38):1907-10. PubMed ID: 18785082
    [No Abstract]   [Full Text] [Related]  

  • 58. Ischemic biliary stricture developed after repeated transcatheter arterial chemoembolization diagnosed by percutaneous transhepatic cholangioscopy in a patient with hepatocellular carcinoma.
    Bang BW; Lee DH; Jeong S; Kim JM; Jeon YS; Lee JI; Lee JW; Kwon KS; Kim HG; Shin YW; Kim YS
    Gastrointest Endosc; 2008 Dec; 68(6):1224-6. PubMed ID: 18555248
    [No Abstract]   [Full Text] [Related]  

  • 59. The effect of transcatheter arterial chemoembolization on CYP1A2 activity in patients with hepatocellular carcinoma.
    Huang W; Qu ZQ; Li XD; He P; Ding N; Zhang SL; Wu MC
    J Clin Pharm Ther; 2008 Oct; 33(5):489-93. PubMed ID: 18834363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    Cho YK; Chung JW; Kim JK; Ahn YS; Kim MY; Park YO; Kim WT; Byun JH
    Cancer; 2008 Jan; 112(2):352-61. PubMed ID: 18008352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.